X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
humans (4) 4
aged (3) 3
female (3) 3
male (3) 3
medicine (3) 3
middle aged (3) 3
abridged index medicus (2) 2
anemia (2) 2
patients (2) 2
pharmacology & pharmacy (2) 2
risk (2) 2
survival (2) 2
acute-pancreatitis (1) 1
adamantane - administration & dosage (1) 1
adamantane - adverse effects (1) 1
adamantane - analogs & derivatives (1) 1
adamantane - therapeutic use (1) 1
adult (1) 1
aged, 80 and over (1) 1
albumin (1) 1
albumins (1) 1
albumins - therapeutic use (1) 1
aml progression (1) 1
analysis (1) 1
angiogenesis inhibitors (1) 1
antibiotics (1) 1
antidiabetics (1) 1
ascites (1) 1
ascites - etiology (1) 1
ascites - therapy (1) 1
association (1) 1
bacterial infections (1) 1
biological products (1) 1
biomedicine (1) 1
biosimilar (1) 1
biosimilar pharmaceuticals (1) 1
blood glucose - metabolism (1) 1
body weight (1) 1
cardiac & cardiovascular systems (1) 1
cardiology and cardiovascular medicine (1) 1
cardiovascular (1) 1
care and treatment (1) 1
chromosome 5 (1) 1
chromosome deletion (1) 1
chronic kidney failure (1) 1
cirrhosis (1) 1
clinical trials (1) 1
clinical-practice (1) 1
clonal deletion (1) 1
comparative analysis (1) 1
cost analysis (1) 1
cytogenetics (1) 1
darbepoetin alfa (1) 1
del (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetes mellitus, type 2 - epidemiology (1) 1
diabetics (1) 1
dipeptidyl peptidase-4 inhibitors (1) 1
diuretics - administration & dosage (1) 1
diuretics - adverse effects (1) 1
dpp4 inhibitors and glp1 receptor agonists (1) 1
drug therapy, combination (1) 1
drug utilization (1) 1
drug-related side effects and adverse reactions (1) 1
drug-resistance (1) 1
efficacy (1) 1
endocrinology & metabolism (1) 1
endocrinology, diabetes and metabolism (1) 1
epoetin alfa (1) 1
epoetin alpha (1) 1
erythropoiesis (1) 1
erythropoiesis-stimulating agents (1) 1
erythropoietin (1) 1
erythropoietin, recombinant (1) 1
failure (1) 1
furosemide (1) 1
furosemide - administration & dosage (1) 1
furosemide - adverse effects (1) 1
genetic research (1) 1
glucagon (1) 1
glycated hemoglobin a - analysis (1) 1
glycosylated hemoglobin (1) 1
hematinics (1) 1
hematology (1) 1
hemoglobin (1) 1
hospitals (1) 1
hx575 (1) 1
hyperkalemia - chemically induced (1) 1
hypoglycemic agents - administration & dosage (1) 1
hypoglycemic agents - adverse effects (1) 1
hypoglycemic agents - therapeutic use (1) 1
hyponatremia - chemically induced (1) 1
improves (1) 1
incretin-mimetics and incretin-enhancers (1) 1
infections (1) 1
infectious diseases (1) 1
italy - epidemiology (1) 1
kaplan-meier estimate (1) 1
kidney diseases (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 11/2018, Volume 392, Issue 10158, pp. 1623 - 1624
Journal Article
by Caraceni, Paolo and Riggio, Oliviero and Angeli, Paolo and Alessandria, Carlo and Neri, Sergio and Neri, Elga and Foschi, Francesco G and Levantesi, Fabio and Airoldi, Aldo and Boccia, Sergio and Svegliati-Baroni, Gianluca and Fagiuoli, Stefano and Romanelli, Roberto G and Cozzolongo, Raffaele and Di Marco, Vito and Sangiovanni, Vincenzo and Morisco, Filomena and Toniutto, Pierluigi and Tortora, Annalisa and De Marco, Rosanna and Angelico, Mario and Cacciola, Irene and Elia, Chiara and Elia, Gianfranco and Federico, Alessandro and Massironi, Sara and Guarisco, Riccardo and Galioto, Alessandra and Ballardini, Giorgio and Rendina, Maria and Nardelli, Silvia and Piano, Salvatore and Prestianni, Loredana and Cappa, Federica Mirici and Cesarini, Lucia and Simone, Loredana and Pasquale, Chiara and Cavallin, Marta and Andrealli, Alida and Fidone, Federica and Ruggeri, Matteo and Roncadori, Andrea and Baldassarre, Maurizio and Tufoni, Manuel and Zaccherini, Giacomo and Bernardi, Mauro and Domenicali, Marco and Giannone, Ferdinando A and Merli, Manuela and Gioia, Stefania and Fasolato, Silvano and Sticca, Antonietta and Campion, Daniela and Risso, Alessandro and Saracco, Giorgio M and Maiorca, Daniela and Rizzotto, Agostino and Lanzi, Arianna and Visani, Anna and Mastroianni, Antonio and Alberti, Alberto B and Mazzarelli, Chiara and Vangeli, Marcello and Marzioni, Marco and Capretti, Francesca and Kostandini, Alba and Magini, Giulia and Colpani, Maria and Laffi, Giacomo and Gabbani, Tommaso and Marsico, Maria and Zappimbulso, Marianna and Petruzzi, Josè and Calvaruso, Vincenza and Parrella, Giovanni and Caporaso, Nicola and Auriemma, Francesco and Guarino, Maria and Pugliese, Fabio and Gasbarrini, Antonio and Leo, Pietro and De Leonardis, Francesco and Pecchioli, Alessandra and Rossi, Piera and Raimondo, Giovanni and Negri, Elisa and Dallio, Marcello and Loguercio, Carmelina and Conte, Dario and Celli, Natascia and Bringiotti, Roberto and Castellaneta, Nicola M and Salerno, Francesco and ANSWER Study Investigators
The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10138, pp. 2417 - 2429
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2018, Volume 101, Issue 1, pp. 78 - 85
Objective The most typical cytogenetic aberration in myelodysplastic syndromes is del(5q), which, when isolated, is associated with refractory anaemia and good... 
lenalidomide | registry study | del(5q) | myelodysplastic syndromes | AML PROGRESSION | SURVIVAL | RISK | TRANSFUSION-DEPENDENT PATIENTS | MUTATIONS | HEMATOLOGY | MDS | Genetic research | Cytogenetics | Care and treatment | Angiogenesis inhibitors | Anemia | Myelodysplastic syndromes | Clonal deletion | Hematology | Remission | Chromosome deletion | Chromosome 5 | Myelodysplastic syndrome
Journal Article
by Castagna, Antonella and Ferrara, Micol and Galli, Laura and Comi, Laura and Sterrantino, Gaetana and Cenderello, Giovanni and Zaccarelli, Mauro and Focà, Emanuele and Roncadori, Andrea and Lazzarin, Adriano and Chichino, G and Mantia, E and Butini, L and Costantini, A and Giacometti, A and Tavio, M and Grassini, M and Valle, M and Vaccher, E and Martellotta, F and Schioppa, O and Maggiolo, F and Viale, P and Borderi, M and Calza, L and Moratello, L and Magistrelli, E and Castelli, F and Festa, E and Quirino, T and Campus, M and Businco, F and Celesia, B.M and La Rosa, R and Pan, A and Fornabaio, C and Mazzotta, F and Di Pietro, M and Bartoloni, A and Ferrara, S and Mastroianni, A and Di Cesare, S and Viscoli, C and Di Biagio, A and Cassola, G and Penco, G and Cericola, A and Nencioni, C and Carli, T and Viganò, P and Re, T and Del Fiorentino, A and Gattuso, G and Palvarini, L and Taurozzi, M and Gianotti, N and Galizzi, N and Poli, A and Rusconi, S and Galli, S.E. Salvaggio M and Rizzardini, G and Mussini, C and Menozzi, M and Gori, A and Muscatello, A and Cappelletti, E and Gargiulo, M and Garavelli, P.L and Bargiacchi, O and Prestileo, T and Di Lorenzo, F and Bonanno, S and Ferrari, C and degli Antoni, A.M and Cattelan, A.M and Gulminetti, R and Pagnucco, L and Menichetti, F and Iapoce, R and Baldelli, F and Schiaroli, E and Italiani, F and Aquilini, D and Magnani, G and Corsini, R and Barchi, E and Ferrari, E and Antinori, A and Cristaudo, A and Latini, A and Cauda, R and Vullo, V and Maffongelli, G and Andreoni, M and Sassett, L and Viviani, F and De Luca, A and Rossetti, B and Franco, A and Resta, F and ... and PRESTIGIO Study Grp and PRESTIGIO Study Group
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 01/2018, Volume 73, Issue 1, pp. 177 - 182
Objectives: This study evaluated the virological efficacy of dolutegravir 50 mg twice daily in 190 HIV-1 failing antiretroviral-experienced patients with... 
VIRAL LOAD | INFECTIOUS DISEASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | DRUG-RESISTANCE
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1693 - 1693
Abstract In Italy the use of lenalidomide (LEN) in MDS with del(5q) is ruled by a national agency (AIFA, Agenzia Italiana del Farmaco) Registry since 2008. We... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3850 - 3850
Abstract Abstract 3850 Background: Lenalidomide (LEN) is available in Italy for patients with intermediate-1- and low-risk myelodysplastic syndromes (MDS)... 
Journal Article
Nutrition, Metabolism and Cardiovascular Diseases, ISSN 0939-4753, 2014, Volume 24, Issue 12, pp. 1346 - 1353
Abstract Background and aims In Italy, the reimbursed use of incretin mimetics and incretin enhancers was subject to enrollment of patients into a web-based... 
Cardiovascular | Type 2 diabetes | Real clinical practice | Incretin-mimetics and incretin-enhancers | Monitoring registry | DPP4 inhibitors and GLP1 receptor agonists | METFORMIN | POPULATION | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | RISK | MELLITUS | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | NUTRITION & DIETETICS | ENDOCRINOLOGY & METABOLISM | THERAPIES | ACUTE-PANCREATITIS | CLINICAL-PRACTICE | ASSOCIATION | Glycated Hemoglobin A - analysis | Triazoles - administration & dosage | Triazoles - adverse effects | Body Weight | Metformin - therapeutic use | Humans | Middle Aged | Pyrazines - administration & dosage | Pyrrolidines - administration & dosage | Pyrrolidines - adverse effects | Male | Pyrazines - therapeutic use | Drug Utilization | Peptides - administration & dosage | Diabetes Mellitus, Type 2 - epidemiology | Pyrrolidines - therapeutic use | Nitriles - administration & dosage | Monitoring, Physiologic | Hypoglycemic Agents - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Adamantane - therapeutic use | Venoms - administration & dosage | Female | Registries | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Venoms - adverse effects | Pyrazines - adverse effects | Sex Factors | Venoms - therapeutic use | Italy - epidemiology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Peptides - therapeutic use | Nitriles - therapeutic use | Diabetics | Safety and security measures | Glucagon
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.